Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» cancer
cancer
Larkspur Biosciences Launches with $35.5 Million in Financing to Build the Next Precision Immunotherapies to Outsmart Cancer
Larkspur Biosciences Launches with $35.5 Million in Financing to Build the Next Precision Immunotherapies to Outsmart Cancer
Globe Newswire
Larkspur Biosciences
immunotherapy
cancer
funding
Flag link:
LabGenius utilizing machine learning to ‘transform’ cancer treatment
LabGenius utilizing machine learning to ‘transform’ cancer treatment
Biopharma Reporter
LabGenius
machine learning
antibody discovery
artificial intelligence
cancer
Flag link:
Drug Shortages Near an All-Time High, Leading to Rationing
Drug Shortages Near an All-Time High, Leading to Rationing
NY Times, NY
drug shortages
cancer
generics
Flag link:
Takeda puts $510M on the line to expand KSQ cancer collaboration
Takeda puts $510M on the line to expand KSQ cancer collaboration
Fierce Biotech
Takeda
KSQ Therapeutics
cancer
oncology
Flag link:
Why Shares of Cassava Sciences Jumped Last Week
Why Shares of Cassava Sciences Jumped Last Week
Motley Fool
Cassava Sciences
Simulfilam
oncology
cancer
Flag link:
FibroGen grabs an option to buy cancer drug startup Fortis
FibroGen grabs an option to buy cancer drug startup Fortis
BioPharma Dive
FibroGen
Fortis Therapeutics
cancer
FOR46
Flag link:
Cash-rich BioNTech broadens scope as COVID shot sales slide
Cash-rich BioNTech broadens scope as COVID shot sales slide
Yahoo/Reuters
BioNTech
earnings
vaccines
COVID-19
cancer
Flag link:
Experts spar over the benefits of liquid biopsy to catch cancer
Experts spar over the benefits of liquid biopsy to catch cancer
Stat
cancer
diagnostics
liquid biopsy
Flag link:
Incyte whittles down pipeline, scrapping 6 R&D programs
Incyte whittles down pipeline, scrapping 6 R&D programs
Fierce Biotech
Incyte
R7D
anemia
cancer
Flag link:
Novartis plant cleared to produce in-demand cancer drug
Novartis plant cleared to produce in-demand cancer drug
BioPharma Dive
Novartis
drug manufacturing
Pluvicto
New Jersey
cancer
radiopharmaceuticals
Flag link:
BMS signs ADC development deal with Munich-based biotech worth more than $1B
BMS signs ADC development deal with Munich-based biotech worth more than $1B
Medical Marketing and Media
Bristol Myers Squibb
Tubulius
cancer
solid tumors
antibody-drug conjugate
Flag link:
Moderna & Merck plan Phase 3 trial for cancer vaccine with Keytruda
Moderna & Merck plan Phase 3 trial for cancer vaccine with Keytruda
Biopharma Reporter
Merck
Moderna Therapeutics
cancer
cancer vaccines
Keytruda
clinical trials
Flag link:
Medivir presents new data at AACR showing significantly improved antitumor efficacy in non-clinical tumor models with fostrox in triple combination
Medivir presents new data at AACR showing significantly improved antitumor efficacy in non-clinical tumor models with fostrox in triple combination
BioSpace
Medivir
AACR
fostrox
cancer
Flag link:
Argenx, Genmab pool expertise on antibody discovery, joining forces to expand into new therapeutic areas
Argenx, Genmab pool expertise on antibody discovery, joining forces to expand into new therapeutic areas
Fierce Biotech
Genmab
Argenx
antibody discovery
drug discovery
cancer
immunology
Flag link:
TORL BioTherapeutics launches with $158M to target cancer
TORL BioTherapeutics launches with $158M to target cancer
Labiotech.eu
TORL BioTherapeutics
cancer
funding
biologics
Flag link:
Function Oncology raises $28M to use CRISPR to tailor cancer diagnosis and treatment
Function Oncology raises $28M to use CRISPR to tailor cancer diagnosis and treatment
BioPharma Dive
Function Oncology
CRISPR
diagnostics
funding
cancer
Flag link:
GSK outlines deal to send cell therapies back to Adaptimmune
GSK outlines deal to send cell therapies back to Adaptimmune
BioPharma Dive
GSK
Adaptimmune Therapeutics
cancer
cell therapy
Flag link:
Moderna Stock Yo-Yoes Winning A Key Battle For Its Cancer Vaccine
Moderna Stock Yo-Yoes Winning A Key Battle For Its Cancer Vaccine
Investors Business Daily
Moderna Therapeutics
Merck
MRNA
cancer
vaccines
Europe
cancer vaccine
Flag link:
Merck/Eisai Drops Melanoma Program for Keytruda-Lenvima Combo After Phase III Fail
Merck/Eisai Drops Melanoma Program for Keytruda-Lenvima Combo After Phase III Fail
BioSpace
Merck
Keytruda
Eisai
Lenvima
melanoma
clinical trials
cancer
colorectal cancer
Flag link:
AbbVie removes two approvals for blood cancer drug Imbruvica
AbbVie removes two approvals for blood cancer drug Imbruvica
BioPharma Dive
AbbVie
Imbruvica
cancer
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »